166 related articles for article (PubMed ID: 11282664)
21. Management of the brown recluse spider bite.
Rees R; Shack RB; Withers E; Madden J; Franklin J; Lynch JB
Plast Reconstr Surg; 1981 Nov; 68(5):768-73. PubMed ID: 7291346
[TBL] [Abstract][Full Text] [Related]
22. Molecular cloning and functional characterization of two isoforms of dermonecrotic toxin from Loxosceles intermedia (brown spider) venom gland.
da Silveira RB; Pigozzo RB; Chaim OM; Appel MH; Dreyfuss JL; Toma L; Mangili OC; Gremski W; Dietrich CP; Nader HB; Veiga SS
Biochimie; 2006 Sep; 88(9):1241-53. PubMed ID: 16581177
[TBL] [Abstract][Full Text] [Related]
23. Effect of hyperbaric oxygen on sphingomyelinase D activity of brown recluse spider (Loxosceles reclusa) venom as studied by 31P nuclear magnetic resonance spectroscopy.
Merchant ML; Hinton JF; Geren CR
Am J Trop Med Hyg; 1997 Mar; 56(3):335-8. PubMed ID: 9129539
[TBL] [Abstract][Full Text] [Related]
24. Toxicity of two North American Loxosceles (brown recluse spiders) venoms and their neutralization by antivenoms.
de Roodt AR; Estevez-Ramírez J; Litwin S; Magaña P; Olvera A; Alagón A
Clin Toxicol (Phila); 2007 Sep; 45(6):678-87. PubMed ID: 17849243
[TBL] [Abstract][Full Text] [Related]
25. Persistent segmental cutaneous anesthesia after a brown recluse spider bite.
Gross AS; Wilson DC; King LE
South Med J; 1990 Nov; 83(11):1321-3. PubMed ID: 2173149
[TBL] [Abstract][Full Text] [Related]
26. Histopathological findings in rabbits after experimental acute exposure to the Loxosceles intermedia (brown spider) venom.
Ospedal KZ; Appel MH; Fillus Neto J; Mangili OC; Sanches Veiga S; Gremski W
Int J Exp Pathol; 2002 Dec; 83(6):287-94. PubMed ID: 12657137
[TBL] [Abstract][Full Text] [Related]
27. Passive hemagglutination inhibition test for diagnosis of brown recluse spider bite envenomation.
Barrett SM; Romine-Jenkins M; Blick KE
Clin Chem; 1993 Oct; 39(10):2104-7. PubMed ID: 8403394
[TBL] [Abstract][Full Text] [Related]
28. Brown recluse spider (Loxosceles reclusa) venom phospholipase D (PLD) generates lysophosphatidic acid (LPA).
Lee S; Lynch KR
Biochem J; 2005 Oct; 391(Pt 2):317-23. PubMed ID: 15926888
[TBL] [Abstract][Full Text] [Related]
29. Comparison of colchicine, dapsone, triamcinolone, and diphenhydramine therapy for the treatment of brown recluse spider envenomation: a double-blind, controlled study in a rabbit model.
Elston DM; Miller SD; Young RJ; Eggers J; McGlasson D; Schmidt WH; Bush A
Arch Dermatol; 2005 May; 141(5):595-7. PubMed ID: 15897381
[TBL] [Abstract][Full Text] [Related]
30. Cutaneous loxoscelism caused by Loxosceles similis venom and neutralization capacity of its specific antivenom.
Chatzaki M; Horta CC; Almeida MO; Pereira NB; Mendes TM; Dias-Lopes C; Guimarães G; Moro L; Chávez-Olórtegui C; Horta MC; Kalapothakis E
Toxicon; 2012 Jul; 60(1):21-30. PubMed ID: 22465492
[TBL] [Abstract][Full Text] [Related]
31. Tetracycline protects against dermonecrosis induced by Loxosceles spider venom.
Paixão-Cavalcante D; van den Berg CW; Gonçalves-de-Andrade RM; Fernandes-Pedrosa Mde F; Okamoto CK; Tambourgi DV
J Invest Dermatol; 2007 Jun; 127(6):1410-8. PubMed ID: 17218940
[TBL] [Abstract][Full Text] [Related]
32. Brown spider envenomation.
Peterson ME
Clin Tech Small Anim Pract; 2006 Nov; 21(4):191-3. PubMed ID: 17265904
[TBL] [Abstract][Full Text] [Related]
33. Loxosceles venom Sphingomyelinase D activates human blood leukocytes: Role of the complement system.
Manzoni-de-Almeida D; Squaiella-Baptistão CC; Lopes PH; van den Berg CW; Tambourgi DV
Mol Immunol; 2018 Feb; 94():45-53. PubMed ID: 29257998
[TBL] [Abstract][Full Text] [Related]
34. Changes in hematological, hemostatic and biochemical parameters induced experimentally in rabbits by Loxosceles gaucho spider venom.
Tavares FL; Sousa-e-Silva MC; Santoro ML; Barbaro KC; Rebecchi IM; Sano-Martins IS
Hum Exp Toxicol; 2004 Oct; 23(10):477-86. PubMed ID: 15553173
[TBL] [Abstract][Full Text] [Related]
35. Platelet aggregation and sphingomyelinase D activity of a purified toxin from the venom of Loxosceles reclusa.
Kurpiewski G; Forrester LJ; Barrett JT; Campbell BJ
Biochim Biophys Acta; 1981 Dec; 678(3):467-76. PubMed ID: 6274420
[TBL] [Abstract][Full Text] [Related]
36. Acute generalized exanthematous pustulosis and Coombs-positive hemolytic anemia in a child following Loxosceles reclusa envenomation.
Lane L; McCoppin HH; Dyer J
Pediatr Dermatol; 2011; 28(6):685-688. PubMed ID: 22082464
[TBL] [Abstract][Full Text] [Related]
37. Enzymatic characterization, antigenic cross-reactivity and neutralization of dermonecrotic activity of five Loxosceles spider venoms of medical importance in the Americas.
Barbaro KC; Knysak I; Martins R; Hogan C; Winkel K
Toxicon; 2005 Mar; 45(4):489-99. PubMed ID: 15733571
[TBL] [Abstract][Full Text] [Related]
38. Interaction of brown recluse spider venom on cell membranes: the inciting mechanism?
Rees RS; Nanney LB; Yates RA; King LE
J Invest Dermatol; 1984 Oct; 83(4):270-5. PubMed ID: 6481179
[TBL] [Abstract][Full Text] [Related]
39. Dapsone use in Loxosceles reclusa envenomation: is there an indication?
Bryant SM; Pittman LM
Am J Emerg Med; 2003 Jan; 21(1):89-90. PubMed ID: 12563594
[No Abstract] [Full Text] [Related]
40. Sphingomyelinase D activity of brown recluse spider (Loxosceles reclusa) venom as studied by 31P-NMR: effects on the time-course of sphingomyelin hydrolysis.
Merchant ML; Hinton JF; Geren CR
Toxicon; 1998 Mar; 36(3):537-45. PubMed ID: 9637373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
